Skip to main content
. 2026 Aug 19;15(9):258. doi: 10.21037/gs-2026-0261

Table 1. Patients’ demographic and clinical characteristics.

Variables Total (n=60) Implant-based reconstruction (n=30) Pedicled TRAM flap reconstruction (n=30) P value
Age (years) 45.75±8.11 43.03±6.08 48.47±9.04 0.009
Underlying diseases 0.31
   Yes 11 (18.3) 4 (14.3) 7 (23.3)
   No 49 (81.3) 26 (86.7) 24 (80.0)
Specific underlying diseases
   Diabetes mellitus 2 (3.3) 1 (3.3) 1 (3.3) >0.99
   Hypertension 3 (5.0) 1 (3.3) 2 (6.7) >0.99
   Dyslipidemia 2 (3.3) 0 (0.0) 2 (6.7) 0.49
   Thalassemia 2 (3.3) 1 (3.3) 1 (3.3) >0.99
Tumor type 0.69
   IDC 45 (75.0) 24 (80.0) 21 (70.0)
   DCIS 9 (15.0) 4 (13.3) 5 (16.7)
   Others 6 (10.0) 2 (6.7) 4 (13.3)
Pathological stage 0.88
   DCIS 6 (10.2) 3 (10.3) 3 (10.3)
   1 12 (20.3) 7 (23.3) 5 (17.2)
   2 31 (52.5) 16 (53.3) 15 (51.7)
   3 10 (16.9) 4 (13.3) 6 (20.7)
Type of mastectomy 0.19
   Modified radical mastectomy (sentinel lymph node-positive or clinically node-positive) 33 (55.0) 14 (46.7) 19 (63.3)
   Total mastectomy 27 (45.0) 16 (53.3) 11 (36.7)

Data are presented as mean ± standard deviation or n (%). DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; TRAM, transverse rectus abdominis myocutaneous.